- Methodology article
- Open Access
A strategy to study tyrosinase transgenes in mouse melanocytes
© Lavado et al; licensee BioMed Central Ltd. 2005
- Received: 01 November 2004
- Accepted: 12 April 2005
- Published: 12 April 2005
A number of transgenic mice carrying different deletions in the Locus Control Region (LCR) of the mouse tyrosinase (Tyr) gene have been developed and analysed in our laboratory. We require melanocytes from these mice, to further study, at the cellular level, the effect of these deletions on the expression of the Tyr transgene, without potential interference with or from the endogenous Tyr alleles. It has been previously reported that it is possible to obtain and immortalise melanocyte cell cultures from postnatal mouse skin.
Here, we describe the efforts towards obtaining melanocyte cultures from our Tyr transgenic mice. We have bred our Tyr transgenic mice into Tyr c-32DSDmutant background, lacking the endogenous Tyr locus. In these conditions, we failed to obtain immortalised melanocytes. We decided to include the inactivation of the Ink4a-Arf locus to promote melanocyte immortalisation. For this purpose, we report the segregation of the Ink4a-Arf null allele from the brown (Tyrp1 b ) mutation in mice. Finally, we found that Ink4a-Arf +/- and Ink4a-Arf -/- melanocytes had undistinguishable tyrosine hydroxylase activities, although the latter showed reduced cellular pigmentation content.
The simultaneous presence of precise genomic deletions that include the tyrosinase locus, such as the Tyr c-32DSDallele, the Tyr transgene itself and the inactivated Ink4a-Arf locus in Tyrp1 B genetic background appear as the crucial combination to perform forthcoming experiments. We cannot exclude that Ink4a-Arf mutations could affect the melanin biosynthetic pathway. Therefore, subsequent experiments with melanocytes will have to be performed in a normalized genetic background regarding the Ink4a-Arf locus.
- Yeast Artificial Chromosome
- Melanin Content
- Locus Control Region
- Tyrosine Hydroxylase Activity
- Immortal Cell Line
Eukaryotic genes are organised on chromosomes in units known as expression domains, that are believed to include all regulatory elements required for correct gene expression . We use the mouse tyrosinase locus (Tyr) as an experimental model to study mammalian expression domains [2, 3]. The mouse Tyr gene is located in chromosome 7 , encodes the rate-limiting enzyme in melanin biosynthesis and is tightly regulated during development, being exclusively expressed in neural crest-derived melanocytes and optic cup-derived retinal pigment epithelium (RPE) cells [5, 6].
Classically, the approach used to functionally identify regulatory elements has been testing a series of DNA constructs containing different amounts of regulatory sequences in transgenic animals. Minigene Tyr constructs were able to rescue the albino phenotype of recipient animals, but displayed variability in pigmentation [7, 8]. In contrast, the generation of transgenic mice with a 250 kb yeast artificial chromosome (YAC) covering the entire mouse Tyr locus completely rescued the albino phenotype, resulting in mice that were indistinguishable from agouti wild-type pigmented mice [9, 10]. These results pointed to the existence of important regulatory elements, absent in previous standard constructs, such as the locus control region (LCR), identified 15 kb upstream of the mouse Tyr promoter [11, 12]. The LCR is necessary to establish the proper expression pattern of the mouse tyrosinase gene. The absence of the LCR resulted in weaker pigmentation, variegated expression in the melanocytes and RPE cells and delayed retinal pigmentation in transgenic mice . Moreover, two binding boxes for nuclear factors within the LCR core, known as boxes A and B, were identified by in vitro analysis  and, recently, have been incorporated into a new boundary activity associated within the LCR region . We have generated transgenic mice with new YAC Tyr transgenes carrying a range of specific mutations within the LCR region .
To address a more detailed study, both at the functional and structural level (using biochemical and cellular approaches), of the role of LCR-variants in these different transgenes, a number of problems had to be solved, including: (1), the dispersed nature of melanocytes which prevented us from direct analysis of relevant tissues, such as skin, where many other unrelated cell types are found; (2), the tyrosinase albino allele (Tyr c ), present in all recipient mouse strains used for the generation of transgenic mice, carrying a reported point-mutation within the coding region that results in a non-functional protein, without the transcriptional status of the locus being affected [16–18], and, , although it has been demonstrated that it is possible to obtain mouse melanocyte immortal cell lines from postnatal skins [19–22], often it becomes difficult to overcome the senescence period that all primary cell cultures undergo.
In this study we describe our efforts and the strategy to obtain melanocyte cell cultures from YAC Tyr transgenic mice in a genetic background lacking the endogenous mouse tyrosinase gene, and the effect of the inactivation of the Ink4a-Arf locus  on proliferation, senescence and tyrosinase activity of established melanocyte cell lines.
Transfer of YAC Tyr transgenes from albino outbred NMRI mice (Tyr c / Tyr c ) to a Tyr c-32DSD/ Tyr c-32DSDbackground
Melanocyte primary cultures of YAC Tyr/∅ ; Tyr c-32DSD/ Tyr c-32DSD
To gain further insight on a series of YAC Tyr transgenic mice carrying a range of deletions around the LCR [10, 12], we decided to prepare cell lines that could be representative of these animals. Chromatin analyses cannot be done in tissue samples obtained directly from transgenic animals, due to the low number of cells expressing the Tyr gene (RPE cells and melanocytes) and the complexity of the tissues or organs containing these cells (eye and skin, respectively). In addition, the presence of the mutated, but transcriptionally active [16–18], albino Tyr locus in all transgenic mice generated to date could interfere with the interpretation and the acquisition of experimental data. To avoid this problem we mobilised the YAC Tyr transgenes to a genetic background lacking the endogenous mouse gene, as shown in Fig. 1, and then we tried to establish melanocyte cultures from these mice.
Mouse melanocyte primary cultures and their corresponding immortalised cell lines have been established from a number of mutant mice [25–29], although this type of cell lines can be sometimes difficult to achieve, as it may be inferred from these listed publications, in which reported cell lines have been generated by the same laboratory. A number of parameters can influence the success in obtaining immortalised melanocytes from mice. First, skins from mouse pups are used as starting material, carrying bacteria and other microorganisms that can contaminate the cultures. Second, and most important, melanocytes, as any somatic cell line in culture, undergo a senescence step previous to their immortalisation. Due to the low number or surviving cells after this senescence step, cells need to be cultured continuously during a minimum of 3–6 months to obtain an immortal cell line [19, 20]. In most of the cultures we did not observe melanocytes after the senescence step (Fig. 2A–C). These results were obtained with all different primary cultures, regardless of their genotype, indicating a problem at the immortalisation step.
Segregation of the Ink4a-Arf locus from the Tyrp1 b locus
It has been reported that melanocyte immortal cell lines (i.e. melan-a and melan-c) lack the p16 protein, most likely due to the lost of the Ink4a-Arf locus during the culture process . Melanocytes from Ink4a-Arf (-/-) null mice proliferate exponentially without showing any signs of senescence, thus it has been proposed that the generation of melanocyte immortal cell lines in an Ink4a-Arf null background would be much easier . Comparable results had been obtained before with fibroblast cultures from Ink4a-Arf homozygous mutant mice . The absence of p16 leads to the inhibition in the inactivation of CDK4 and CDK6. These kinases inactivate the retinoblastoma pathway, promoting the proliferation of the cells [32, 33]. Therefore, we decided to mobilise the Ink4a-Arf null allele into our YAC Tyr transgenic mice.
Ink4a/Arf- null strain in a pure C57BL/6J genetic background and unlinked from the mutant Tyrp1 b allele were obtained to avoid the confounding presence of the Tyrp1 b allele. Ink4a-Arf +/- mice were backcrossed seven times with wild-type C57BL/6J mice, eventually yielding Ink4a-Arf +/- ; Tyrp1 B / Tyrp1 b mice. These mice were intercrossed to produce a number of Ink4a-Arf -/- mice that were in their majority Ink4a-Arf -/- ; Tyrp1 b / Tyrp1 b and, accordingly, had a brown coat. Exceptionally, one mouse (from a total population of 27 Ink4a-Arf -/- mice) was identified as an Ink4a-Arf -/- but had a black coat. This mouse turned out to represent a recombinant with an Ink4a-Arf -/- ; Tyrp1 B / Tyrp1 b genotype. From this animal, and after the appropriate crosses, a strain of mice in C57BL/6J background that were Ink4a-Arf -/- ; Tyrp1 B / Tyrp1 B was obtained (Fig. 3), and used for subsequent experiments.
Melanocyte primary cultures from Tyrp1 B / Tyrp1 B Ink4a-Arf mutant mice
Tyrosinase activity and melanin content in the melanocyte cultures from Ink4a-Arf mutant mice
A valid approach to analyse the role of the different regulatory regions of the mouse Tyr gene in the transcription of the locus and, eventually, in the amount of mature protein being made, is the measurement of the enzymatic activity of the derived Tyr protein. We measured the levels of Tyr enzymatic activity and melanin content using reported procedures  in melanocyte cultures, to study the influence of the presence or absence of the p16 protein in the expression of the Tyr gene. Tyrosine hydroxylase activity values from Ink4a-Arf -/- and Ink4a-Arf +/- cell extracts were undistinguishable and significantly lower to values obtained in melan-a cells (Fig. 4B). However, the quantity of melanin in the proliferative Ink4a-Arf -/- melanocytes cell cultures was significantly lower than in Ink4a-Arf +/- or melan-a cells (Fig. 4C).
Differences in melanin content could be explained by different individual cell culture response to TPA or/and CT that are present in cell culture medium. However, the observed differences in cellular pigmentation were maintained after removing CT from cell culture medium. In addition, TPA is always required as an additive to maintain cellular proliferation. Increasing the amount of TPA does not result in a parallel increase in pigmentation, opposite to what is observed with CT.
Differences in melanin content could also be explained by the control of the retinoblastoma (RB) protein by p16, and the observation that RB protein interacts with the transcription factor microphthalmia (Mift) , that controls the expression of the Tyr gene. Differences between Ink4a-Arf mutant cells and melan-a could be due to the presence of a number of additional alterations in this latter immortal cell line, such as the loss of expression of p16Ink4a . The recent generation of mice with increased gene dosage of Ink4a-Arf will be instrumental to further investigate the influence of this locus on Tyr activity .
With all these results we can conclude that the simultaneous presence of:  at least one mutant allele of the Ink4a-Arf locus; , the Tyr c-32DSDmutant albino allele in homozygosis and; , the presence of the relevant Tyr transgene in heterozygosis, are required for the establishment and the study of immortal mouse melanocyte cultures from transgenic mice carrying Tyr constructs. Finally, we cannot exclude that Ink4a-Arf mutations could affect the melanin biosynthetic pathway. Therefore, experiments with mouse melanocytes will have to be performed in a normalized genetic background regarding the Ink4a-Arf locus.
Four types of mice were used in this study: YRT2 YAC tyrosinase heterozygous transgenic mice in an albino outbred NMRI background (YRT2/∅ ; Tyr c / Tyr c ) (line #1999) , 32DSD radiation induced albino mutant mice (Tyr c-32DSD/ Tyr c-32DSD) , homozygous Ink4a-Arf mutant mice (Tyr + / Tyr + ; Tyrp1 b / Tyrp1 b ; Ink4a-Arf -/-) in C57BL/6J genetic background  and wild-type pigmented C57BL/6J mice. All experiments complied with local and European legislation concerning vivisection and the experimentation and use of animals for research purposes.
Southern blot analysis
The discrimination of the endogenous tyrosinase gene from the YAC-tyrosinase transgenes was performed as previously described, using the RFLP probe, containing exon 2 of the mouse tyrosinase gene [9, 12]. To obtain an endogenous internal control, membranes were co-hybridised with a single-copy mouse gene, the p19 Arf E1 probe, a Eco R I DNA fragment, 230 bp in length, containing exon 1 of the p19 Arf gene (pRSp19arfE1 plasmid, generous gift from M. Malumbres). In brief, genomic DNA was isolated from mice tail tips and prepared for southern blot as described . 15–20 μg of genomic DNA were digested with Eco R I (Roche, Basel, Switzerland), fractionated by horizontal gel electrophoresis in 0,8% agarose and transferred to a Hybond-N nylon membrane (Amersham, Buckinghamshire, UK) by capillary blotting. RFLP and p19 Arf E1 DNA probes were labelled with [α32P] dCTP using the High Prime labelling kit (Roche). Membranes were hybridised in Southern hybridisation solution (0.25 M Na2HPO4 pH = 7.2, 7% SDS, 1% BSA) overnight at 65°C, washed at 65°C in 20 mM Na2HPO4 pH = 7.2, 1% SDS, 1 mM EDTA pH = 8 and resulting blots exposed for 1–3 days and scanned with a PhosphorImager (Molecular Dynamics, Sunnyvale, CA, USA). Quantification of the hybridisation signals was performed using the ImageQuant v1.2 software (Molecular Dynamics).
Genotyping of the Ink4a-Arf and Tyrp1 loci
The Ink4a-Arf and Tyrp1 loci were genotyped by PCR as follows. The Ink4a-Arf wild-type allele was specifically detected using primers that amplify Ink4a-Arf exon 2: mp16F, 5'-ATGATGATGGGCAACGTTC-3' and mp16R, 5'-CAAATATCGCACGATGTC-3'. The Ink4a-Arf null allele, which has a neo-cassette substituting exons 2 and 3 , was genotyped using primers that hybridise, respectively, with the neo-cassette (oligo Neo) and with Ink4a-Arf flanking genomic sequences (oligo R1): Neo, 5'-CTATCAGGACATAGCGTTGG-3' and R1, 5'-AGTGAGAGTTTGGGGACA GAG-3'. To genotype the Tyrp1 locus, two different PCR reactions were performed to amplify, respectively, exons 4 and 5 of the Tyrp1 gene. Amplification of exon 4 was performed using primers: Tyrp1-4F, 5'-CTGCGATGTCTGCACTGATGACTT-3' and Tyrp1-4R, 5'-AGGGTATCGTACTCTTCCAAGGAT-3'. Amplification of exon 5 was performed using primers: Tyrp1-5F, 5'-ACAGCACTGAGGGTGGACCAATC-3' and Tyrp1-5R, 5'-AGGGTATCGTACTCTTCCAAGGAT-3'. After amplification, the product corresponding to exon 4 was digested with Taq I, and the product corresponding to exon 5 was digested with Hga I. Digestion mixtures were separated in standard agarose gels and visualized with ethidium bromide. The Tyrp1 b mutant allele does not contain neither of the previous restriction sites, Taq I and Hga I, whereas both enzymes digest the Tyrp1 B wild-type allele. PCR reactions had 3 mM MgCl2, 1% DMSO, 2.5 mM dNTPs (Epicentre, Madison, WI, USA), 20 pmol of each primer, and 0.25 μl of Taq-Gold (Applied Biosystems, Foster City, CA, USA). In addition, each reaction had approximately 100 ng of genomic DNA extracted from the tail tips. Annealing temperature was 60°C and PCR reactions were carried on for 30 amplification cycles.
Melanocyte cultures were prepared, essentially, as previously described . Briefly, dorsal skin biopsies were obtained from pups of all investigated genotypes between +19.5 and +22.5 d.p.c. stages (postnatal P2–P3). Dorsal skin was split in 5 μg/ml trypsin (Sigma, St. Louis, MO, USA) in PBS and the epidermal layer then minced with a pair of surgical blades in 250 μg/ml trypsin and 200 μg/ml EDTA in PBS. Cells were cultured on a feeder layer of mitomycin-treated murine XB2 keratinocytes . The cells were grown in RPMI-1640 medium containing 2 mM glutamine, 10% fetal calf serum, 100000 U/l penicillin, 100 mg/l streptomycin sulphate (all from Invitrogen, Carlsbad, CA, USA), 200 nM tetradecanoyl phorbol acetate (TPA) (Sigma) and 200 pM cholera toxin (CT) (Sigma), at 37°C, 95% humidity and 10% CO2 pressure. Explant cultures from different donor mice were kept separate. Passages were made when cultures became subconfluent, and melanocytes were counted at each passage. Feeder cells were added when necessary. Control melan-a and melan-c cells, derived from inbred C57BL/6J and outbred albino LAC-MF1 mice, respectively, were cultured as previously described [19, 20].
Quantification of melanin and tyrosinase enzymatic activities
Melanin contents in whole cell extracts were measured by spectrophotometer essentially as described . In brief, 6 × 106 cells from ~day 70 of culture were collected and homogenised in 300 μl of PBS, 100 μl of homogenate incubated for 14–16 hours at room temperature with 900 μl of 2 M NaOH, 20% DMSO and absorbance measured at 470 nm.
Tyrosinase enzymatic activities were recorded following described assays [41, 46, 47]. In brief, for tyrosine hydroxylase activity, 6 × 106 cells from ~day 70 of culture were collected and cell extracts were prepared in 10 mM Sodium Phosphate buffer pH = 6.8 to which Tween-20 (Igepal) was added (1% final concentration) prior the assay. Reaction volume included 10 μl of L-DOPA 250 mM, 10 μl of L-[3,5-3H]-Tyrosine mix (450 μl of L-Tyrosine 262 μM in 10 mM Sodium Phosphate buffer pH = 6.8 and 50 μl L-[3,5-3H]-Tyrosine [1 mCi/ml, 46 Ci/mmol, Amersham]), 20 μl of Sodium Phosphate buffer pH = 6.8 and 10 μl of cell extracts, was incubated for 1 hour at 37°C, and stopped by adding 450 μl trichloracetic acid (TCA) 1% (Merck, Darmstadt, Germany). A small amount of absorbing substrate (active carbon [Merck] and Celite 545 [Fluka, St. Gallen, Switzerland], 1:1) was added, mixed for 30 min at room temperature and centrifuged. Radioactivity from clear supernatants (100 μl) was measured in a β-scintillation counter (Beckmann, Fullerton, CA, USA).
This work was supported by funds from the Spanish Ministry of Science and Technology Bio2000-1653 and Bio2003-08196 to LM and SAF2002-03402 to MS. All experiments complied with local and European legislation concerning vivisection and the experimentation and use of animals for research purposes. The authors are grateful to D. Bennett and E. Sviderskaya for melan-a and melan-c cells, for their continuous support and for generous teaching of melanocyte culture methods, to E. Rinchik, S. Shinpocks and P. Hunsicker (ORNL) for kindly providing albino 32DSD cryopreserved mouse embryos, to J. Fernandez and S. Montalbán for rescueing the 32DSD mouse stock at CNB, to J.C. García-Borrón for useful comments and to P. Cozar and M. Cantero for technical assistance with mouse colonies. Correspondence and request for materials should be addressed to Lluís Montoliu email@example.com.
- Bonifer C: Developmental regulation of eukaryotic gene loci: which cis-regulatory information is required?. Trends Genet. 2000, 16: 310-315. 10.1016/S0168-9525(00)02029-1.View ArticlePubMedGoogle Scholar
- Giraldo P, Montoliu L: Size matters: use of YACs, BACs and PACs in transgenic animals. Transgenic Res. 2001, 10: 83-103. 10.1023/A:1008918913249.View ArticlePubMedGoogle Scholar
- Montoliu L: Gene transfer strategies in animal transgenesis. Cloning Stem Cells. 2002, 4: 39-46. 10.1089/153623002753632039.View ArticlePubMedGoogle Scholar
- Regales L, Giraldo P, Garcia-Diaz A, Lavado A, Montoliu L: Identification and functional validation of a 5' upstream regulatory sequence in the human tyrosinase gene homologous to the locus control region of the mouse tyrosinase gene. Pigment Cell Res. 2003, 16: 685-692. 10.1046/j.1600-0749.2003.00100.x.View ArticlePubMedGoogle Scholar
- Beermann F, Schmid E, Schutz G: Expression of the mouse tyrosinase gene during embryonic development: recapitulation of the temporal regulation in transgenic mice. Proc Natl Acad Sci U S A. 1992, 89: 2809-2813.PubMed CentralView ArticlePubMedGoogle Scholar
- Gimenez E, Lavado A, Giraldo P, Montoliu L: Tyrosinase expression is not detected in mouse brain outside the retinal pigment epithelium cells. European J of Neurosc. 2003, 18: 2673-2676. 10.1046/j.1460-9568.2003.02992.x.View ArticleGoogle Scholar
- Beermann F, Ruppert S, Hummler E, Bosch FX, Muller G, Ruther U, Schutz G: Rescue of the albino phenotype by introduction of a functional tyrosinase gene into mice. EMBO J. 1990, 9: 2819-2826.PubMed CentralPubMedGoogle Scholar
- Schedl A, Beermann F, Thies E, Montoliu L, Kelsey G, Schutz G: Transgenic mice generated by pronuclear injection of a yeast artificial chromosome. Nucleic Acids Res. 1992, 20: 3073-3077.PubMed CentralView ArticlePubMedGoogle Scholar
- Schedl A, Montoliu L, Kelsey G, Schutz G: A yeast artificial chromosome covering the tyrosinase gene confers copy number-dependent expression in transgenic mice. Nature. 1993, 362: 258-261. 10.1038/362258a0.View ArticlePubMedGoogle Scholar
- Giraldo P, Montoliu L: Artificial chromosome transgenesis in pigmentary research. Pigment Cell Res. 2002, 15: 258-264. 10.1034/j.1600-0749.2002.02030.x.View ArticlePubMedGoogle Scholar
- Porter S, Larue L, Mintz B: Mosaicism of tyrosinase-locus transcription and chromatin structure in dark vs. light melanocyte clones of homozygous chinchilla-mottled mice. Dev Genet. 1991, 12: 393-402. 10.1002/dvg.1020120604.View ArticlePubMedGoogle Scholar
- Montoliu L, Umland T, Schutz G: A locus control region at -12 kb of the tyrosinase gene. EMBO J. 1996, 15: 6026-6034.PubMed CentralPubMedGoogle Scholar
- Gimenez E, Giraldo P, Jeffery G, Montoliu L: Variegated expression and delayed retinal pigmentation during development in transgenic mice with a deletion in the locus control region of the tyrosinase gene. Genesis. 2001, 30: 21-25. 10.1002/gene.1028.View ArticlePubMedGoogle Scholar
- Ganss R, Montoliu L, Monaghan AP, Schutz G: A cell-specific enhancer far upstream of the mouse tyrosinase gene confers high level and copy number-related expression in transgenic mice. EMBO J. 1994, 13: 3083-3093.PubMed CentralPubMedGoogle Scholar
- Giraldo P, Martinez A, Regales L, Lavado A, Garcia-Diaz A, Alonso A, Busturia A, Montoliu L: Functional dissection of the mouse tyrosinase locus control region identifies a new putative boundary activity. Nucleic Acids Res. 2003, 31: 6290-6305. 10.1093/nar/gkg793.PubMed CentralView ArticlePubMedGoogle Scholar
- Jackson IJ, Bennett DC: Identification of the albino mutation of mouse tyrosinase by analysis of an in vitro revertant. Proc Natl Acad Sci U S A. 1990, 87: 7010-7014.PubMed CentralView ArticlePubMedGoogle Scholar
- Shibahara S, Okinaga S, Tomita Y, Takeda A, Yamamoto H, Sato M, Takeuchi T: A point mutation in the tyrosinase gene of BALB/c albino mouse causing the cysteine-serine substitution at position 85. Eur J Biochem. 1990, 189: 455-461. 10.1111/j.1432-1033.1990.tb15510.x.View ArticlePubMedGoogle Scholar
- Yokohama T, Silversides DW, Waymire KG, Kwon BS, Takeuchi T, Overbeek PA: Conserved cysteine to serine mutation in tyrosinase is responsible for the classical albino mutation in laboratory mice. Nucleic Acids Res. 1990, 18: 7293-7298.View ArticleGoogle Scholar
- Bennett DC, Cooper PJ, Dexter TJ, Devlin LM, Heasman J, Nester B: Cloned mouse melanocyte lines carrying the germline mutations albino and brown: complementation in culture. Development. 1985, 105: 379-385.Google Scholar
- Bennett DC, Cooper PJ, Hart IR: A line of non-tumorigenic mouse melanocytes, syngeneic with the B16 melanoma and requiring a tumour promoter for growth. Int J Cancer. 1987, 39: 414-418.View ArticlePubMedGoogle Scholar
- Tamura A, Halaban R, Moellmann G, Cowan JM, Lerner MR, Lerner AB: Normal murine melanocytes in culture. In Vitro Cell Dev Biol. 1987, 23: 519-522.View ArticlePubMedGoogle Scholar
- Halaban R, Moellmann G, Tamura A, Kwon BS, Kuklinska E, Pomerantz SH, Lerner AB: Tyrosinases of murine melanocytes with mutations at the albino locus. Proc Natl Acad Sci U S A. 1988, 85: 7241-7245.PubMed CentralView ArticlePubMedGoogle Scholar
- Serrano M, Lee H, Chin L, Cordon-Cardo C, Beach D, DePinho RA: Role of the INK4a locus in tumor suppression and cell mortality. Cell. 1996, 85: 27-37. 10.1016/S0092-8674(00)81079-X.View ArticlePubMedGoogle Scholar
- Rinchik EM, Stoye JP, Frankel WN, Coffin J, Kwon BS, Russell LB: Molecular analysis of viable spontaneous and radiation-induced albino (c)-locus mutations in the mouse. Mutat Res. 1993, 286: 199-207.View ArticlePubMedGoogle Scholar
- Spanakis E, Lamina P, Bennett DC: Effects of the developmental colour mutations silver and recessive spotting on proliferation of diploid and immortal mouse melanocytes in culture. Development. 1992, 114: 675-680.PubMedGoogle Scholar
- Sviderskaya EV, Bennett DC, Ho L, Bailin T, Lee ST, Spritz RA: Complementation of hypopigmentation in p-mutant (pink-eyed dilution) mouse melanocytes by normal human P cDNA, and defective complementation by OCA2 mutant sequences. J Invest Dermatol. 1997, 108: 30-34. 10.1111/1523-1747.ep12285621.View ArticlePubMedGoogle Scholar
- Sviderskaya EV, Novak EK, Swank RT, Bennett DC: The murine misty mutation: phenotypic effects on melanocytes, platelets and brown fat. Genetics. 1998, 148: 381-390.PubMed CentralPubMedGoogle Scholar
- Suzuki T, Li W, Zhang O, Novak EK, Sviderskaya EV, Wilson A, Bennett DC, Roe BA, Swank RT, Spritz RA: The gene mutated in cocoa mice, carrying a deffect of organelle biogenesis, is a homologue of the human Hermansky-Pudlak syndrome-3 gene. Genomics. 2001, 78: 30-37. 10.1006/geno.2001.6644.View ArticlePubMedGoogle Scholar
- Suzuki T, Li W, Zhang O, Karim A, Novak EK, Sviderskaya EV, Hill SP, Bennett DC, Levin AV, Nieuwenhuis HK, Fong CT, Castellan C, Miterski B, Swank RT, Spritz RA: Hermasky-Pudlak syndrome is caused by mutations in HPS4, the human homolog of the mouse light-ear gene. Nat Genet. 2002, 30: 321-324.PubMedGoogle Scholar
- Sviderskaya EV, Hill SP, Evans-Whipp TJ, Chin L, Orlow SJ, Easty DJ, Cheong SC, Beach D, DePinho RA, Bennett DC: p16(Ink4a) in melanocyte senescence and differentiation. J Natl Cancer Inst. 2002, 94: 446-454.View ArticlePubMedGoogle Scholar
- Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW: Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 1997, 88: 593-602. 10.1016/S0092-8674(00)81902-9.View ArticlePubMedGoogle Scholar
- Serrano M, Hannon GJ, Beach D: A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature. 1993, 366: 704-707. 10.1038/366704a0.View ArticlePubMedGoogle Scholar
- Sharpless NE, DePinho RA: The INK4A/ARF locus and its two gene products. Curr Opin Genet Dev. 1999, 9: 22-30. 10.1016/S0959-437X(99)80004-5.View ArticlePubMedGoogle Scholar
- del Marmol V, Beermann F: Tyrosinase and related proteins in mammalian pigmentation. FEBS Lett. 1996, 381: 165-168. 10.1016/0014-5793(96)00109-3.View ArticlePubMedGoogle Scholar
- Sviderskaya EV, Gray-Schopfer VC, Hill SP, Smit NP, Evans-Whipp TJ, Bond J, Hill L, Bataille V, Peters G, Kipling D, Wynford-Thomas D, Bennett DC: p16/cyclin-dependent kinase inhibitor 2A deficiency in human melanocyte senescence, apoptosis, and immortalization: possible implications for melanoma progression. J Natl Cancer Inst. 2003, 95: 723-732.View ArticlePubMedGoogle Scholar
- Toyofuku K, Wada I, Valencia JC, Kushimoto T, Ferrans VJ, Hearing VJ: Oculocutaneous albinism types 1 and 3 are ER retention diseases: mutation of tyrosinase or Tyrp1 can affect the processing of both mutant and wild-type proteins. FASEB J. 2001, 15: 2149-2161. 10.1096/fj.01-0216com.View ArticlePubMedGoogle Scholar
- Zdarsky E, Favor J, Jackson IJ: The molecular basis of brown, an old mouse mutation, and of an induced revertant to wild type. Genetics. 1990, 126: 443-449.PubMed CentralPubMedGoogle Scholar
- Ioffe E, Liu Y, Bhaumik M, Poirier F, Factor SM, Stanley P: WW6: an embryonic stem cell line with an inert genetic marker that can be traced in chimeras. Proc Natl Acad Sci U S A. 1995, 92: 7357-7361.PubMed CentralView ArticlePubMedGoogle Scholar
- Obata M, Lee GH, Kanda H, Kitagawa T, Ogawa K: Loss of heterozygosity at loci on chromosome 4, a common genetic event during the spontaneous immortalization of mouse embryonic fibroblasts. Mol Carcinog. 1997, 19: 17-24. 10.1002/(SICI)1098-2744(199705)19:1<17::AID-MC3>3.0.CO;2-K.View ArticlePubMedGoogle Scholar
- Orlow I, Lacombe L, Hannon GJ, Serrano M, Pellicer I, Dalbagni G, Reuter VE, Zhang ZF, Beach D, Cordon-Cardo C: Deletion of the p16 and p15 genes in human bladder tumors. J Natl Cancer Inst. 1995, 87: 1524-1529.View ArticlePubMedGoogle Scholar
- Gimenez E, Lavado A, Giraldo P, Cozar P, Jeffery G, Montoliu L: A transgenic mouse model with inducible Tyrosinase gene expression using the tetracycline (Tet-on) system allows regulated rescue of abnormal chiasmatic projections found in albinism. Pigment Cell Res. 2004, 17: 363-370. 10.1111/j.1600-0749.2004.00158.x.View ArticlePubMedGoogle Scholar
- Yavuzer U, Keenan E, Lowings P, Vachtenheim J, Currie G, Goding CR: The Microphthalmia gene product interacts with the retinoblastoma protein in vitro and is a target for deregulation of melanocyte-specific transcription. Oncogene. 1995, 10: 123-134.PubMedGoogle Scholar
- Matheu A, Pantoja C, Efeyan A, Criado LM, Martín-Caballero J, Flores JM, Klatt P, Serrano M: Increased gene dosage of Ink4a/Arf results in cancer resistance and normal aging. Genes Dev. 2004, 18: 2736-2746. 10.1101/gad.310304.PubMed CentralView ArticlePubMedGoogle Scholar
- Rheinwald JG, Green H: Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinising colonies from single cells. Cell. 1975, 6: 331-334. 10.1016/0092-8674(75)90183-X.View ArticlePubMedGoogle Scholar
- Donatien PD, Orlow SJ: Interaction of melanosomal proteins with melanin. Eur J Biochem. 1995, 232: 159-164. 10.1111/j.1432-1033.1995.tb20794.x.View ArticlePubMedGoogle Scholar
- Pomerantz SH: Tyrosine hydroxylation catalysed by mammalian tyrosinase: an improved method of assay. Biochem Biophys Res Comun. 1964, 16: 188-194. 10.1016/0006-291X(64)90359-6.View ArticleGoogle Scholar
- Solano F, García-Borron JC: Advances in enzymatic analysis of melanogenesis. The Pigmentary System: Physiology and Pathophysiology. Edited by: Norlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne JP. 1998, New York: Oxford University Press, 461-471.Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.